4//SEC Filing
GOLDSTEIN ALLAN L 4
Accession 0000914190-19-000345
CIK 0000707511other
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 2:29 PM ET
Size
18.2 KB
Accession
0000914190-19-000345
Insider Transaction Report
Form 4
GOLDSTEIN ALLAN L
Director
Transactions
- Gift
Common Stock
2019-06-12−228,000→ 1,712,793 total
Holdings
- 150,000
Stock Option (right to buy)
Exercise: $0.28Exp: 2027-09-01→ Common Stock (150,000 underlying) - 450,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2021-03-25→ Common Stock (450,000 underlying) - 250,000
Stock Option (right to buy)
Exercise: $0.36Exp: 2022-06-30→ Common Stock (250,000 underlying) - 200,000
Stock Option (right to buy)
Exercise: $0.64Exp: 2023-03-16→ Common Stock (200,000 underlying) - 250,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2028-07-17→ Common Stock (250,000 underlying) Convertible Promissory Note (right to buy)
Exercise: $0.12From: 2019-02-27Exp: 2024-02-27→ Common Stock (20,833 underlying)- 15,625
Common Stock Warrant (right to buy)
Exercise: $0.18From: 2019-08-27Exp: 2024-02-27→ Common Stock (15,625 underlying) - 410,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2029-05-15→ Common Stock (410,000 underlying) Convertible Promissory Note (right to buy)
Exercise: $0.12From: 2019-05-13Exp: 2024-05-13→ Common Stock (20,833 underlying)- 15,625
Common Stock Warrant (right to buy)
Exercise: $0.18From: 2019-11-13Exp: 2024-05-13→ Common Stock (15,625 underlying)
Footnotes (4)
- [F1]100% vested.
- [F2]37,500 shares vest on each of 9/1/17, 9/1/18, 9/1/19 and 9/1/20.
- [F3]62,500 shares vest on each of 7/17/18, 7/17/19, 7/17/20 and 7/17/21.
- [F4]102,500 shares vest on each of 5/15/19, 5/15/20, 5/15/21 and 5/15/22.
Documents
Issuer
REGENERX BIOPHARMACEUTICALS INC
CIK 0000707511
Entity typeother
Related Parties
1- filerCIK 0000905390
Filing Metadata
- Form type
- 4
- Filed
- Aug 27, 8:00 PM ET
- Accepted
- Aug 28, 2:29 PM ET
- Size
- 18.2 KB